Viewing Study NCT06993506


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2026-05-31 @ 4:07 AM
Study NCT ID: NCT06993506
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-29
First Post: 2025-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-negative Breast Cancer View
None Recurrence View
None Metastasis View
Keywords: